138 related articles for article (PubMed ID: 35369705)
1. Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
Bergmark BA; Marston NA; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Park JG; Murphy SA; Verma S; Wojakowski W; Terra SG; Sabatine MS; Wiviott SD;
Circulation; 2022 May; 145(18):1377-1386. PubMed ID: 35369705
[TBL] [Abstract][Full Text] [Related]
2. Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.
Zimerman A; Wiviott SD; Park JG; Murphy SA; Ran X; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Verma S; Wojakowski W; Terra SG; Sabatine MS; Bergmark BA; Marston NA
Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38484368
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
Zimerman A; Wiviott SD; Park JG; Murphy SA; Ran X; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Verma S; Wojakowski W; Terra SG; Sabatine MS; Bergmark BA; Marston NA
J Clin Lipidol; 2024; 18(2):e261-e268. PubMed ID: 38158248
[TBL] [Abstract][Full Text] [Related]
4. ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L; Di Martino M; Neufeld T; Fraum TJ; Kang CJ; Burks KH; Di Costanzo A; Minicocci I; Bini S; Maranghi M; Pigna G; Labbadia G; Zheng J; Fierro D; Montali A; Ceci F; Catalano C; Davidson NO; Lucisano G; Nicolucci A; Arca M; Stitziel NO
Circulation; 2023 Nov; 148(19):1479-1489. PubMed ID: 37712257
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.
Burks KH; Basu D; Goldberg IJ; Stitziel NO
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101688. PubMed ID: 35999139
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetic and pharmacokinetic-pharmacodynamic analysis of vupanorsen from phase I and phase II studies.
Ahn JE; Terra SG; Liu J
CPT Pharmacometrics Syst Pharmacol; 2023 Jul; 12(7):988-1000. PubMed ID: 37170423
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
Hussain A; Sun C; Selvin E; Nambi V; Coresh J; Jia X; Ballantyne CM; Hoogeveen RC
Eur J Prev Cardiol; 2022 Mar; 29(2):e53-e64. PubMed ID: 33580780
[TBL] [Abstract][Full Text] [Related]
8. Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
Bergmark BA; Marston NA; Prohaska TA; Alexander VJ; Zimerman A; Moura FA; Murphy SA; Goodrich EL; Zhang S; Gaudet D; Karwatowska-Prokopczuk E; Tsimikas S; Giugliano RP; Sabatine MS;
N Engl J Med; 2024 May; 390(19):1770-1780. PubMed ID: 38587249
[TBL] [Abstract][Full Text] [Related]
9. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
Rosenson RS; Gaudet D; Hegele RA; Ballantyne CM; Nicholls SJ; Lucas KJ; San Martin J; Zhou R; Muhsin M; Chang T; Hellawell J; Watts GF;
N Engl J Med; 2024 May; ():. PubMed ID: 38809174
[TBL] [Abstract][Full Text] [Related]
10. ANGPTL3 is a novel HDL component that regulates HDL function.
Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D
J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity.
Kraaijenhof JM; Tromp TR; Nurmohamed NS; Reeskamp LF; Langenkamp M; Levels JHM; Boekholdt SM; Wareham NJ; Hoekstra M; Stroes ESG; Hovingh GK; Grefhorst A
J Am Heart Assoc; 2023 Nov; 12(21):e030476. PubMed ID: 37889183
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits.
Hoffmann WG; Chen YQ; Schwartz CS; Barber JL; Dev PK; Reasons RJ; Miranda Maravi JS; Armstrong B; Gerszten RE; Silbernagel G; Konrad RJ; Bouchard C; Sarzynski MA
J Lipid Res; 2024 Feb; 65(2):100495. PubMed ID: 38160757
[TBL] [Abstract][Full Text] [Related]
13. Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial.
Gaudet D; Pall D; Watts GF; Nicholls SJ; Rosenson RS; Modesto K; San Martin J; Hellawell J; Ballantyne CM
JAMA Cardiol; 2024 Apr; ():. PubMed ID: 38583092
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus.
Liu S; Ke J; Feng X; Wang Z; Wang X; Yang L; Zhao D
J Diabetes Res; 2024; 2024():2431441. PubMed ID: 38577301
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism.
Burks KH; Xie Y; Gildea M; Jung IH; Mukherjee S; Lee P; Pudupakkam U; Wagoner R; Patel V; Santana K; Alisio A; Goldberg IJ; Finck BN; Fisher EA; Davidson NO; Stitziel NO
J Lipid Res; 2024 Feb; 65(2):100500. PubMed ID: 38219820
[TBL] [Abstract][Full Text] [Related]
16. Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line.
Rossi I; Marodin G; Lupo MG; Adorni MP; Papotti B; Dall'Acqua S; Ferri N
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612519
[TBL] [Abstract][Full Text] [Related]
17. Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
Gobeil É; Bourgault J; Mitchell PL; Houessou U; Gagnon E; Girard A; Paulin A; Manikpurage HD; Côté V; Couture C; Marceau S; Bossé Y; Thériault S; Mathieu P; Vohl MC; Tchernof A; Arsenault BJ
Eur Heart J; 2024 Mar; 45(9):707-721. PubMed ID: 38243829
[TBL] [Abstract][Full Text] [Related]
18.
Pennisi G; Maurotti S; Ciociola E; Jamialahmadi O; Bertolazzi G; Mirarchi A; Bergh PO; Scionti F; Mancina RM; Spagnuolo R; Tripodo C; Boren J; Petta S; Romeo S
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1086-1097. PubMed ID: 38385290
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical Effects of Prolonged Insufficient Sleep on Lipid Profile: A Pooled Analysis of 2 Randomized Trials.
Barragán R; Zuraikat FM; Cheng B; Scaccia SE; Cochran J; Aggarwal B; Jelic S; St-Onge MP
J Am Heart Assoc; 2023 Oct; 12(20):e032078. PubMed ID: 37815115
[TBL] [Abstract][Full Text] [Related]
20. The serum levels of angiopoietin-like protein 3 and 4 in type 2 diabetic patients with and without metabolic syndrome compared to the control group.
Hezarkhani S; Hajighaderi A; Hosseinzadeh S; Behnampour N; Veghari G; Fathabadi F; Hesari Z; Joshaghani HR
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e466. PubMed ID: 38140923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
